Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ProShares Ultra Bloomberg Natural Gas ETF (BOIL) vs Davita Inc (DVA) Price & Performance

ProShares Ultra Bloomberg Natural Gas ETFTrade
Davita IncTrade

Price performance (Past 24H)

Key statistics

ProShares Ultra Bloomberg Natural Gas ETF vs Davita Inc — how do they compare? ProShares Ultra Bloomberg Natural Gas ETF trades at $20.87, while Davita Inc trades at $179.02 (market cap $11.72B). The key difference: Davita Inc is trading nearer its 52-week high, ProShares Ultra Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.

BOILDVA
Sector
Leveraged / InverseHealth
52-Week High
$87.24$240.96
52-Week Low
$18.74$103.87
Market Cap
$11.72B
Enterprise Value
$24.44B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ProShares Ultra Bloomberg Natural Gas ETF

BOIL trades at $19.12, up 2.03% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The stock faces resistance near $20 and support at $18. Recent news highlights natural gas market volatility and company-specific updates, including an investor webcast and annual meeting results. Financial ratios are unavailable, limiting fundamental assessment.

The outlook remains cautious due to bearish technicals and reliance on natural gas price swings. Risks include energy market fluctuations and competitive pressures. Analyst sentiment is mixed, with some viewing BOIL as a tactical tool amid volatility, but the lack of fundamental data warrants careful evaluation for long-term investment.

Davita Inc

DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.

The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ProShares Ultra Bloomberg Natural Gas ETF

BOIL is a leveraged ETF that seeks to provide two times (2x) the daily performance of the Bloomberg Natural Gas Subindex. It uses futures contracts to offer magnified exposure to natural gas price movements.

Read more on BOIL

About Davita Inc

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Read more on DVA